Celldex Therapeutics buy Canaccord Genuity Group Inc.
Start price
22.07.26
/
50%
€30.47
Target price
22.07.27
€52.60
Performance (%)
9.48%
Price
31.07.26
€32.95
Summary
This prediction is currently active. With a performance of 9.48%, the BUY prediction by Canaccord_Genuity_Gr for Celldex Therapeutics is trending in the right direction. This prediction currently runs until 22.07.27. The prediction end date can be changed by Canaccord_Genuity_Gr at any time. Canaccord_Genuity_Gr has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Celldex Therapeutics | 7.399% |
| iShares Core DAX® | 2.591% |
| iShares Nasdaq 100 | -0.915% |
| iShares Nikkei 225® | 0.145% |
| iShares S&P 500 | -0.367% |
Comments by Canaccord_Genuity_Gr for this prediction
In the thread Celldex Therapeutics diskutieren
Celldex Therapeutics (CLDX) had its price target lowered by Canaccord Genuity Group Inc. from $62.00 to $60.00. They now have a "buy" rating on the stock.
Ratings data for CLDX provided by MarketBeat